NCI-MATCH is structured into numerous sub-protocols, each testing a different targeted therapy. The trial employs a "master protocol" design, allowing for the addition of new sub-studies as new targeted therapies and genetic markers are identified. This structure provides flexibility and the ability to rapidly adapt to emerging scientific discoveries.
